These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 22901834)

  • 1. The diagnosis of depression: current and emerging methods.
    Smith KM; Renshaw PF; Bilello J
    Compr Psychiatry; 2013 Jan; 54(1):1-6. PubMed ID: 22901834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seeking an objective diagnosis of depression.
    Bilello JA
    Biomark Med; 2016 Aug; 10(8):861-75. PubMed ID: 27415130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diagnostic structured interviews in child and adolescent's psychiatry].
    Renou S; Hergueta T; Flament M; Mouren-Simeoni MC; Lecrubier Y
    Encephale; 2004; 30(2):122-34. PubMed ID: 15107714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Letter to the Editor: CONVERGENCES AND DIVERGENCES IN THE ICD-11 VS. DSM-5 CLASSIFICATION OF MOOD DISORDERS.
    Cerbo AD
    Turk Psikiyatri Derg; 2021; 32(4):293-295. PubMed ID: 34964106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expert and self-assessment of lifetime symptoms and diagnosis of major depressive disorder in large-scale genetic studies in the general population: comparison of a clinical interview and a self-administered checklist.
    Martin J; Streit F; Treutlein J; Lang M; Frank J; Forstner AJ; Degenhardt F; Witt SH; Schulze TG; Cichon S; Nöthen MM; Rietschel M; Strohmaier J
    Psychiatr Genet; 2017 Oct; 27(5):187-196. PubMed ID: 28731911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Web-based tools can be used reliably to detect patients with major depressive disorder and subsyndromal depressive symptoms.
    Lin CC; Bai YM; Liu CY; Hsiao MC; Chen JY; Tsai SJ; Ouyang WC; Wu CH; Li YC
    BMC Psychiatry; 2007 Apr; 7():12. PubMed ID: 17425774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the Neurobehavioral Functioning Inventory as a depression screening tool after traumatic brain injury.
    Kennedy RE; Livingston L; Riddick A; Marwitz JH; Kreutzer JS; Zasler ND
    J Head Trauma Rehabil; 2005; 20(6):512-26. PubMed ID: 16304488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic evaluation of the hospital depression scale (HADS) and the Beck depression inventory II (BDI-II) in adults with congenital heart disease using a structured clinical interview: Impact of depression severity.
    Westhoff-Bleck M; Winter L; Aguirre Davila L; Herrmann-Lingen C; Treptau J; Bauersachs J; Bleich S; Kahl KG
    Eur J Prev Cardiol; 2020 Mar; 27(4):381-390. PubMed ID: 31349778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The promise of biomarkers in diagnosing major depression in primary care: the present and future.
    Redei EE; Mehta NS
    Curr Psychiatry Rep; 2015 Aug; 17(8):601. PubMed ID: 26081681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The diagnostic accuracy of the Patient Health Questionnaire-2 (PHQ-2), Patient Health Questionnaire-8 (PHQ-8), and Patient Health Questionnaire-9 (PHQ-9) for detecting major depression: protocol for a systematic review and individual patient data meta-analyses.
    Thombs BD; Benedetti A; Kloda LA; Levis B; Nicolau I; Cuijpers P; Gilbody S; Ioannidis JP; McMillan D; Patten SB; Shrier I; Steele RJ; Ziegelstein RC
    Syst Rev; 2014 Oct; 3():124. PubMed ID: 25348422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for poststroke major depression: a meta-analysis of diagnostic validity studies.
    Meader N; Moe-Byrne T; Llewellyn A; Mitchell AJ
    J Neurol Neurosurg Psychiatry; 2014 Feb; 85(2):198-206. PubMed ID: 23385849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accuracy of the PHQ-2 Alone and in Combination With the PHQ-9 for Screening to Detect Major Depression: Systematic Review and Meta-analysis.
    Levis B; Sun Y; He C; Wu Y; Krishnan A; Bhandari PM; Neupane D; Imran M; Brehaut E; Negeri Z; Fischer FH; Benedetti A; Thombs BD; ; Che L; Levis A; Riehm K; Saadat N; Azar M; Rice D; Boruff J; Kloda L; Cuijpers P; Gilbody S; Ioannidis J; McMillan D; Patten S; Shrier I; Ziegelstein R; Moore A; Akena D; Amtmann D; Arroll B; Ayalon L; Baradaran H; Beraldi A; Bernstein C; Bhana A; Bombardier C; Buji RI; Butterworth P; Carter G; Chagas M; Chan J; Chan LF; Chibanda D; Cholera R; Clover K; Conway A; Conwell Y; Daray F; de Man-van Ginkel J; Delgadillo J; Diez-Quevedo C; Fann J; Field S; Fisher J; Fung D; Garman E; Gelaye B; Gholizadeh L; Gibson L; Goodyear-Smith F; Green E; Greeno C; Hall B; Hampel P; Hantsoo L; Haroz E; Harter M; Hegerl U; Hides L; Hobfoll S; Honikman S; Hudson M; Hyphantis T; Inagaki M; Ismail K; Jeon HJ; Jetté N; Khamseh M; Kiely K; Kohler S; Kohrt B; Kwan Y; Lamers F; Asunción Lara M; Levin-Aspenson H; Lino V; Liu SI; Lotrakul M; Loureiro S; Löwe B; Luitel N; Lund C; Marrie RA; Marsh L; Marx B; McGuire A; Mohd Sidik S; Munhoz T; Muramatsu K; Nakku J; Navarrete L; Osório F; Patel V; Pence B; Persoons P; Petersen I; Picardi A; Pugh S; Quinn T; Rancans E; Rathod S; Reuter K; Roch S; Rooney A; Rowe H; Santos I; Schram M; Shaaban J; Shinn E; Sidebottom A; Simning A; Spangenberg L; Stafford L; Sung S; Suzuki K; Swartz R; Tan PLL; Taylor-Rowan M; Tran T; Turner A; van der Feltz-Cornelis C; van Heyningen T; van Weert H; Wagner L; Li Wang J; White J; Winkley K; Wynter K; Yamada M; Zhi Zeng Q; Zhang Y
    JAMA; 2020 Jun; 323(22):2290-2300. PubMed ID: 32515813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of two depression screening instruments in a sleep disorders clinic.
    Law M; Naughton MT; Dhar A; Barton D; Dabscheck E
    J Clin Sleep Med; 2014 Jun; 10(6):683-8. PubMed ID: 24932150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defining mixed depression.
    Benazzi F
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 May; 32(4):932-9. PubMed ID: 18234411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Hospital Anxiety and Depression Scale (HADS) and the 9-item Patient Health Questionnaire (PHQ-9) as screening instruments for depression in patients with cancer.
    Hartung TJ; Friedrich M; Johansen C; Wittchen HU; Faller H; Koch U; Brähler E; Härter M; Keller M; Schulz H; Wegscheider K; Weis J; Mehnert A
    Cancer; 2017 Nov; 123(21):4236-4243. PubMed ID: 28654189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Energy metabolism in major depressive disorder: Recent advances from omics technologies and imaging.
    Gu X; Ke S; Wang Q; Zhuang T; Xia C; Xu Y; Yang L; Zhou M
    Biomed Pharmacother; 2021 Sep; 141():111869. PubMed ID: 34225015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accuracy of Patient Health Questionnaire-9 (PHQ-9) for screening to detect major depression: individual participant data meta-analysis.
    Levis B; Benedetti A; Thombs BD;
    BMJ; 2019 Apr; 365():l1476. PubMed ID: 30967483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic accuracy for major depression in multiple sclerosis using self-report questionnaires.
    Fischer A; Fischer M; Nicholls RA; Lau S; Poettgen J; Patas K; Heesen C; Gold SM
    Brain Behav; 2015 Sep; 5(9):e00365. PubMed ID: 26445703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of depression in children and adolescents.
    Gray LB; Dubin-Rhodin A; Weller RA; Weller EB
    Curr Psychiatry Rep; 2009 Apr; 11(2):106-13. PubMed ID: 19302763
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.